Amyris’s Biossance Brand leads in Clean Beauty with another record quarter; Expands capability and expertise to accelerate ...
July 16 2018 - 09:00AM
In support of its growth strategy to become a global leader in
Clean Beauty, Amyris (NASDAQ:AMRS) has announced two executive
appointments to ensure it can respond quickly to the surging
consumer demand for its Clean Beauty skincare products from
Biossance™, now the fastest selling skincare brand in North
America.
Caroline Hadfield has been promoted to President of Biossance,
and is recognized for leading its launch and subsequent success
with consumers looking for clean, non-toxic skincare that delivers
superior performance. Formerly Senior Vice President of
Personal Care at Amyris, Ms. Hadfield will continue to lead brand
positioning, new product and category innovation and development,
supply chain management and operations. A leading advocate for the
introduction of Clean Beauty in the skincare market, she has
successfully established Biossance as a leader in this rapidly
growing sector of the market, delivering an outstanding range of
Clean Beauty products that meet our No Compromise™ philosophy of
safe, non-toxic ingredients that are efficacious and deliver
superior performance.
In addition, Catherine Gore will join as Senior Vice President,
Sales, Marketing & Education for Biossance. Formerly, a Global
Vice President and General Manager of Kendo, including Marc
Jacobs Beauty, and the Vice President of Merchandising for Sephora
Collection, Ms. Gore will be responsible for revenue growth
and sales channel execution both domestically and internationally.
Ms. Gore brings a strong track record of delivering significant
revenue growth from her recent experience.
“With these two appointments, Biossance is well positioned to
accelerate its growth in Clean Beauty categories, as well as expand
its reach, both internationally and online,” Amyris President and
CEO John Melo said. “This year, Biossance retail sales have climbed
300%. We have successfully set the standard for Clean Beauty in the
skincare market and we are growing rapidly in response to consumer
demand.”
“We are delivering positive impact for our planet and our
shareholders by setting the standard for sustainability in personal
care. Using products with sustainable ingredients is not just a
good choice, we believe it’s the best choice,” Mr. Melo said.
“We make higher quality, sustainable products that perform better.
That is what we mean by Make Good. No Compromise.™ In the
near future, we expect to disrupt Baby Care, the way we are
doing with skincare. We believe that everybody’s skin, no
matter how young or old, deserves the benefits of clean, non-toxic
ingredients, without any petroleum or harmful chemicals.”
About Biossance Pioneering sustainable beauty
through biotechnology, at Biossance we created a 100% plant-based
squalane skincare line that is delivering the leading skin
moisturizer while using only safe and sustainable ingredients. We
formulate with a No Compromise™ approach, proudly blacklisting over
2,000 potentially harmful ingredients because the products you use
make a difference for your health and the health of the planet.
Biossance makes sure only the most trustworthy and powerful
ingredients make the final cut. Because we believe and are
committed to delivering both best performing and clean beauty
products. The full Biossance skin care line can be found
at www.Biossance.com and www.SEPHORA.com.
About AmyrisAmyris is the integrated renewable
products company that is enabling the world’s leading brands to
achieve sustainable growth. Amyris applies its innovative
bioscience solutions to convert plant sugars into hydrocarbon
molecules and produce specialty ingredients and consumer products.
The company is delivering its No Compromise™ products and services
across a number of markets, including specialty and performance
chemicals, flavors and fragrances, cosmetics ingredients,
pharmaceuticals, and nutraceuticals. More information about the
company is available at www.amyris.com.
Forward-Looking StatementsThis release contains
forward-looking statements, and any statements other than
statements of historical fact could be deemed to be forward-looking
statements. These forward-looking statements include, among other
things, statements regarding future events (such as expected growth
for Biossance, including anticipated international and online
expansion, and the expected introduction of Baby Care products),
that involve risks and uncertainties. These statements are based on
management's current expectations and actual results and future
events may differ materially due to risks and uncertainties,
including risks related to Amyris's liquidity and ability to fund
operating and capital expenses, potential delays or failures in
development, production and commercialization of products, risks
related to Amyris's reliance on third parties, and other risks
detailed from time to time in filings Amyris makes with
the Securities and Exchange Commission, including Annual
Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current
Reports on Form 8-K. Amyris disclaims any obligation to update
information contained in these forward-looking statements, whether
as a result of new information, future events, or otherwise.
Amyris, the Amyris logo, Biossance and No Compromise are
trademarks or registered trademarks of Amyris, Inc. in the U.S.
and/or other countries. All other trademarks are the property of
their respective owners.
Contact:Peter DeNardoDirector, Investor
Relations and Corporate CommunicationsAmyris, Inc. +1 (510)
740-7481investor@amyris.compr@amyris.com
Amyris (NASDAQ:AMRS)
Historical Stock Chart
From Feb 2024 to Mar 2024
Amyris (NASDAQ:AMRS)
Historical Stock Chart
From Mar 2023 to Mar 2024